KRYSTAL BIOTECH, INC. (KRYS) scores 81 out of 100 on boothcheck's 11-model valuation framework. Verdict: Excellent The estimated fair value is 142.48, representing a 45% premium to fair value. Quantitative score: 75/100. Qualitative score: 90/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.